TDF 300mg / 3TC 300mg / EFV 400mg, tab.

NST DORATELE2T-

Valid Article

6.4.2.5 - Fixed-dose combinations of antiretroviral medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AR11
Anatomical Therapeutic Chemical Classification according to WHOCC
The order of this product needs to be justified and is only acceptable under certain conditions.
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

TENOFOVIR (TDF) / LAMIVUDINE (3TC)/ EFAVIRENZ (EFV)

Efavirenz (EFV)-based combinations became non-standard. They are no longer the option of choice in first-line HIV treatment according to the WHO guidelines update 2021. Replaced by dolutegravir (DTG)-based combinations.

Therapeutic Action

Fixed-dose combination (FDC) of three antiretrovirals:

Indications

HIV infection

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Storage

Below 25ºC